Pharmacy - Emergency Medicine Deep Dive Podcast – Details, episodes & analysis

Managing anticoagulation in patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD) is a complex clinical challenge. In this episode, we explore the delicate balance between preventing venous thromboembolism (VTE) and minimizing bleeding risks in this vulnerable population. We discuss the evolving role of direct oral anticoagulants (DOACs), including the limited and often controversial evidence supporting their use in ESRD, alongside the continued relevance of warfarin. Drawing on guideline recommendations, observational studies, and emerging research on novel agents such as Factor XI inhibitors, we highlight the nuances of decision-making and the importance of individualized therapy. Whether you’re a clinician, researcher, or learner, this episode provides a concise yet comprehensive look at where the field stands and where it’s headed.

What if treating diabetic ketoacidosis didn’t always require IV drips, ICU beds, or long hospital stays? In this episode, we explore the SQuID protocol, a cutting-edge approach that uses subcutaneous insulin for mild to moderate DKA. Evidence shows it can safely resolve DKA, speed up recovery, and free up critical hospital resources...all while keeping outcomes comparable to traditional treatment. We’ll also discuss the important limitations, safety considerations, and the steps needed before this approach can be widely adopted. Tune in to hear how SQuID could transform the way we manage DKA.

In this episode, we dive into the clinical nuances of using gabapentin and pregabalin for chronic neuropathic pain. Join us as we unpack the evolving approach to gabapentinoid prescribing, including key pharmacologic differences, practical dose limitations, and when to consider switching therapies. Learn why doses of gabapentin above 1800 mg/day may not provide added benefit...and how pregabalin’s consistent absorption and greater binding affinity might offer an effective alternative, even with cost considerations. Whether you're a clinician or simply curious about pain management, this episode brings evidence-based insights to the forefront.

In this episode, we explore how a targeted approach to neurotransmitters such as serotonin, dopamine, and acetylcholine, can optimize antiemetic therapy. We break down key safety concerns for commonly used agents, including QT prolongation with ondansetron, extrapyramidal effects from metoclopramide and phenothiazines, and anticholinergic risks with diphenhydramine. Tune in for practical tips to balance efficacy and safety in managing nausea and vomiting across clinical settings.

In today’s episode, we explore the updated approach to managing status epilepticus. We walk through a practical, stepwise treatment strategy starting with benzodiazepines, followed by ketamine, and then anti-epileptics like levetiracetam and lacosamide. We also cover recommended intubation and general anesthetic choices for refractory cases, emphasizing the importance of early airway management. Stay tuned to sharpen your emergency care skills and improve outcomes for patients facing seizures.

In this episode, we dive into the PREVENT CLOT trial, which compared aspirin to low-molecular-weight heparin (LMWH) for thromboprophylaxis in orthopedic trauma. While the study found aspirin to be noninferior in preventing all-cause mortality, some clinicians raise concerns about its limited generalizability. We break down the findings, the controversy, and what it all means for real-world practice, especially in higher-risk patients. Tune in for a balanced look at evidence-based prophylaxis and the importance of individualized care.

In this episode, we dive into the evolving practice of administering intravenous (IV) push antibiotics, a method gaining traction across emergency departments and outpatient antimicrobial programs. Prompted in part by IV fluid shortages during natural disasters, healthcare providers have increasingly embraced IV push for its speed, efficiency, and potential to reduce hospital stays. We explore what the evidence says about safety, cost savings, and patient outcomes, and discuss the clinical considerations that guide when and when not to use this approach. From resource-strapped EDs to home-based care, IV push antibiotics are reshaping antimicrobial delivery. But is faster always better? Tune in as we unpack the data and practical implications.

In this episode, we explore a groundbreaking case report introducing a novel approach to buprenorphine induction for patients with Opioid Use Disorder, especially those using fentanyl. Learn how low-dose intravenous naloxone is used to safely trigger moderate withdrawal, allowing for immediate buprenorphine initiation and dramatically shortening the induction timeline. Tune in to hear how this protocol could change the way we manage OUD in acute care settings.

This episode covers practical, evidence-informed strategies for reversing anticoagulant and antiplatelet medications in critical bleeding scenarios, including intracerebral hemorrhage. We review reversal protocols for warfarin, dabigatran, and Factor Xa inhibitors, and discuss the roles of PCC, FFP, DDAVP, and tranexamic acid. Key pitfalls in reversal therapy are examined, along with guidance on tailoring interventions to individual patients.

In this episode, we break down how to assess liver injury and understand its impact on drug therapy. We explore the difference between liver enzymes and true liver function tests, why normal labs can be misleading in cirrhosis, and how impaired hepatic metabolism affects drug efficacy and toxicity. Tune in for practical insights on adjusting medications safely in patients with liver dysfunction.